Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients.

WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and ...

A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...

As President Donald Trump huddled with his top advisers in the White House Situation Room on Tuesday, U.S. officials signaled ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.

The lack of movement has left foreign leaders and domestic businesses on edge with a little less than three weeks until Trump’s July 8 deadline for striking trade accords.

A study between University of California and Case Western Reserve University explores "synthetic platelets" to aid ...

RemoteTech Breakthrough, a leading independent market intelligence organization evaluating remote work technologies, today ...

The Korea Research Institute of Chemical Technology's new MoS2 coating boosts the lifespan of anode-free solid-state ...

Nearly 11 years after Theresa Benn's body was discovered in Choccolocco Creek, investigators have returned to a rural stretch ...

Developers have struck a deal with lenders including a hedge fund to end a decade-long impasse over an historic Venetian ...